Development of Orally Disintegrating Tablets Based on a New Excipient

News  |  pharmtech.findpharma.com | Nov 2, 2008

The authors examine the effectiveness of an excipient comprised of mannitol, polyvinyl acetate, and crospovidone using model actives loperamide hydrogen chloride and caffeine by examining the impact of compression speed, tableting force, and the application of a direct compression process.

http://pharmtech.findpharma.com/pharmtech/Ingredients/Orally-Disintegrating-Tablets/ArticleStandard/Article/detail/564662?ref=25

MedlinePlus Medical Encyclopedia: Depression

Depression may be described as feeling sad, blue, unhappy, miserable, or down in the dumps. Most of us feel this way at one time or another for short periods.

http://www.nlm.nih.gov/medlineplus/ency/article/003213.htm

Life Sciences - Research conducted at Astellas Pharma, Inc. has updated our ...

Hirata and colleagues published their study in European Journal of Pharmacology (Effects of serotonin 5-HT(3) receptor antagonists on CRF-induced abnormal colonic water transport and defecation in rats. European Journal of Pharmacology, 2008;587(1-3):281-4). For more information, contact T.

http://www.newsrx.com/health-articles/1073425.html

RANBAXY : Newsroom -> Press Releases

Ranbaxy Laboratories Limited (RLL), announced today that the Company has received approval from the U.S. Food and Drug Administration to manufacture and market Loperamide Hydrochloride and Simethicone Tablets, 2 mg/125 mg (OTC). The Office of Generic Drugs, U.S.

http://www.ranbaxy.com/newsroom/pressrelease_det.asp?sno=295